CN101641095B - 用于治疗细菌感染的组合药物 - Google Patents
用于治疗细菌感染的组合药物 Download PDFInfo
- Publication number
- CN101641095B CN101641095B CN2008800093460A CN200880009346A CN101641095B CN 101641095 B CN101641095 B CN 101641095B CN 2008800093460 A CN2008800093460 A CN 2008800093460A CN 200880009346 A CN200880009346 A CN 200880009346A CN 101641095 B CN101641095 B CN 101641095B
- Authority
- CN
- China
- Prior art keywords
- pharmaceutically acceptable
- acceptable salt
- formula
- antibiotic
- carbapenem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 *c1nc(C(*(O)=O)=[N+])c[s]1 Chemical compound *c1nc(C(*(O)=O)=[N+])c[s]1 0.000 description 5
- ZSKVGTPCRGIANV-ZXFLCMHBSA-N C[C@H]([C@H]([C@@H](C1)N2C(C(O)=O)=C1SCCNC=N)C2=O)O Chemical compound C[C@H]([C@H]([C@@H](C1)N2C(C(O)=O)=C1SCCNC=N)C2=O)O ZSKVGTPCRGIANV-ZXFLCMHBSA-N 0.000 description 1
- TYMABNNERDVXID-DLYFRVTGSA-N C[C@H]([C@H]([C@@H](C1)N2C(C(O)=O)=C1S[C@@H](CC1)CN1C(C)=N)C2=O)O Chemical compound C[C@H]([C@H]([C@@H](C1)N2C(C(O)=O)=C1S[C@@H](CC1)CN1C(C)=N)C2=O)O TYMABNNERDVXID-DLYFRVTGSA-N 0.000 description 1
- ZRPURHGFWCAYFY-GPRNHDLUSA-N C[C@H]([C@H]([C@@H](C1)N2C(C(O)=O)=C1S[C@@H](CC1)CN1C(C)=N)C2O)O Chemical compound C[C@H]([C@H]([C@@H](C1)N2C(C(O)=O)=C1S[C@@H](CC1)CN1C(C)=N)C2O)O ZRPURHGFWCAYFY-GPRNHDLUSA-N 0.000 description 1
- YYEMQPZQJXYJAZ-MOGGRMMLSA-O C[C@H]([C@H]([C@@H]([C@H]1C)N2C(C(C)=O)=C1c([s]1)c[n]3c1c(C(c1c[nH+]ccc1)O)nc3)C2=O)O Chemical compound C[C@H]([C@H]([C@@H]([C@H]1C)N2C(C(C)=O)=C1c([s]1)c[n]3c1c(C(c1c[nH+]ccc1)O)nc3)C2=O)O YYEMQPZQJXYJAZ-MOGGRMMLSA-O 0.000 description 1
- KEDAXBWZURNCHS-YWQPPHKUSA-N C[C@H]([C@H]([C@@H]([C@H]1C)N2C(C(O)=O)=C1SC(C1)CN(C)[C@@H]1C(N(CC1)C[C@H]1NC(CNC(N)=N)=O)=O)C2=O)O Chemical compound C[C@H]([C@H]([C@@H]([C@H]1C)N2C(C(O)=O)=C1SC(C1)CN(C)[C@@H]1C(N(CC1)C[C@H]1NC(CNC(N)=N)=O)=O)C2=O)O KEDAXBWZURNCHS-YWQPPHKUSA-N 0.000 description 1
- KGVWSAODVLCGDQ-WAUNWFAXSA-N C[C@H]([C@H]([C@@H]1N2C(C(O)=O)=C(CC(C3)CN(C)[C@@H]3C(N(CC3)C[C@H]3NC(CNC(N)=N)=O)=O)[C@@H]1C)C2=O)O Chemical compound C[C@H]([C@H]([C@@H]1N2C(C(O)=O)=C(CC(C3)CN(C)[C@@H]3C(N(CC3)C[C@H]3NC(CNC(N)=N)=O)=O)[C@@H]1C)C2=O)O KGVWSAODVLCGDQ-WAUNWFAXSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4162—1,2-Diazoles condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4436—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07006053.8 | 2007-03-23 | ||
| EP07006053 | 2007-03-23 | ||
| PCT/EP2008/053336 WO2008116813A2 (en) | 2007-03-23 | 2008-03-19 | Combination medicaments for treating bacterial infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101641095A CN101641095A (zh) | 2010-02-03 |
| CN101641095B true CN101641095B (zh) | 2012-10-31 |
Family
ID=38293982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008800093460A Expired - Fee Related CN101641095B (zh) | 2007-03-23 | 2008-03-19 | 用于治疗细菌感染的组合药物 |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8486929B2 (https=) |
| EP (1) | EP2124942B1 (https=) |
| JP (2) | JP2010521517A (https=) |
| KR (1) | KR101320718B1 (https=) |
| CN (1) | CN101641095B (https=) |
| AU (1) | AU2008231854B2 (https=) |
| BR (1) | BRPI0809147A2 (https=) |
| CA (1) | CA2680018C (https=) |
| MX (1) | MX2009009918A (https=) |
| NZ (1) | NZ579375A (https=) |
| RU (1) | RU2488394C2 (https=) |
| WO (1) | WO2008116813A2 (https=) |
| ZA (1) | ZA200906349B (https=) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2124942B1 (en) * | 2007-03-23 | 2016-04-27 | Basilea Pharmaceutica AG | Combination medicaments for treating bacterial infections |
| KR20110095856A (ko) * | 2008-12-01 | 2011-08-25 | 글레이드 올가닉스 프라이비트 리미티드 | 아즈트레오남과 카르바페넴류인 메로페넴 및 에르타페넴의 상승작용적 조합 |
| AU2009329169B2 (en) | 2008-12-19 | 2012-06-28 | Pfizer Inc. | Monocarbams |
| CA2807546C (en) | 2010-08-10 | 2022-08-23 | Rempex Pharmaceuticals, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
| KR101315483B1 (ko) * | 2011-06-23 | 2013-10-07 | 주식회사 아리바이오 | 항생제 및 라이소포스파티딜콜린을 포함하는 면역 증강 또는 세균성 감염 질환 치료용 조성물 |
| WO2013033461A1 (en) | 2011-08-31 | 2013-03-07 | Rempex Pharmaceuticals, Inc. | Heterocyclic boronic acid ester derivatives and therapeutic uses thereof |
| UY34585A (es) * | 2012-01-24 | 2013-09-02 | Aicuris Gmbh & Co Kg | Compuestos b-lactámicos sustituidos con amidina, su preparación y uso |
| US9156858B2 (en) | 2012-05-23 | 2015-10-13 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| US10561675B2 (en) | 2012-06-06 | 2020-02-18 | Rempex Pharmaceuticals, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
| MX2015008627A (es) | 2013-01-04 | 2015-09-23 | Rempex Pharmaceuticals Inc | Derivados de acido boronico y usos terapeuticos de los mismos. |
| KR20150103269A (ko) | 2013-01-04 | 2015-09-09 | 렘펙스 파머수티클스 인코퍼레이티드 | 보론산 유도체 및 그의 치료적 용도 |
| US9101638B2 (en) | 2013-01-04 | 2015-08-11 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| US9241947B2 (en) | 2013-01-04 | 2016-01-26 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| EP3139930B1 (en) | 2014-05-05 | 2024-08-14 | Melinta Therapeutics, Inc. | Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof |
| ES2750805T3 (es) | 2014-05-05 | 2020-03-27 | Rempex Pharmaceuticals Inc | Síntesis de sales de boronato y usos de las mismas |
| AU2015264418A1 (en) | 2014-05-19 | 2016-11-10 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| WO2016003929A1 (en) | 2014-07-01 | 2016-01-07 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| US10662205B2 (en) | 2014-11-18 | 2020-05-26 | Qpex Biopharma, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
| US20180051041A1 (en) | 2015-03-17 | 2018-02-22 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| RU2618433C2 (ru) * | 2015-08-10 | 2017-05-03 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Санкт-Петербургский государственный университет" (СПбГУ) | Антимикробная комбинация в отношении устойчивых к карбапенемам грамотрицательных бактерий вида pseudomonas aeruginosa, продуцирующих металло-β-лактамазу |
| MX389349B (es) | 2016-06-30 | 2025-03-20 | Qpex Biopharma Inc | Derivados de ácido borónico y usos terapéuticos de los mismos. |
| CN107641119B (zh) * | 2016-07-21 | 2019-11-08 | 中国科学院上海药物研究所 | 单环β-内酰胺-铁载体轭合物及其制备方法和用途 |
| RU2666619C2 (ru) * | 2016-12-01 | 2018-09-11 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Санкт-Петербургский государственный университет" (СПбГУ) | АНТИМИКРОБНАЯ КОМБИНАЦИЯ В ОТНОШЕНИИ УСТОЙЧИВЫХ К КАРБАПЕНЕМАМ ГРАМОТРИЦАТЕЛЬНЫХ БАКТЕРИЙ ВИДА ACINETOBACTER BAUMANNII, ПРОДУЦИРУЮЩИХ МЕТАЛЛО-β-ЛАКТАМАЗУ |
| US20200093814A1 (en) | 2016-12-21 | 2020-03-26 | Aicuris Gmbh & Co. Kg | Combination therapy with amidine substituted beta-lactam compounds and beta-lactamase inhibitors for infections with antibiotic resistant bacterial strains |
| US11286270B2 (en) | 2017-10-11 | 2022-03-29 | Qpex Biopharma, Inc. | Boronic acid derivatives and synthesis thereof |
| EP3747883A4 (en) | 2018-01-29 | 2020-12-16 | Medshine Discovery Inc. | MONOCYCLIC B-LACTAM COMPOUND FOR TREATING BACTERIAL INFECTION |
| EP3781576B1 (en) | 2018-04-20 | 2024-06-12 | Qpex Biopharma, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| EP3901150B1 (en) | 2018-12-18 | 2025-12-03 | Shenzhen Optimum Biological Technology Co., Ltd | Monocyclic beta-lactam compound for use in the treatment of pneumonia |
| US20220133699A1 (en) | 2019-02-14 | 2022-05-05 | Singapore Eye Research Institute | Antibacterial Compositions |
| US12491180B2 (en) | 2019-12-19 | 2025-12-09 | Shenzhen Optimum Biological Technology Co., Ltd | Application of compound in treating pneumonia |
| AU2021266715A1 (en) | 2020-05-05 | 2022-11-17 | Qpex Biopharma, Inc. | Boronic acid derivatives and synthesis, polymorphic forms, and therapeutic uses thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007065288A2 (en) * | 2005-12-07 | 2007-06-14 | Basilea Pharmaceutica Ag | Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1575803A (en) | 1976-03-09 | 1980-10-01 | Fujisawa Pharmaceutical Co | 3,7 disubstituted 3 cephem 4 carboxylic acid compounds andprocesses for the preparation thereof |
| CA1283404C (en) | 1986-07-01 | 1991-04-23 | Shigeru Sanai | Cephalosporin compounds, processes for their preparation and antibacterial agents |
| US5888998A (en) * | 1997-04-24 | 1999-03-30 | Synphar Laboratories, Inc. | 2-oxo-1-azetidine sulfonic acid derivatives as potent β-lactamase inhibitors |
| US5994340A (en) | 1997-08-29 | 1999-11-30 | Synphar Laboratories, Inc. | Azetidinone derivatives as β-lactamase inhibitors |
| US6916803B2 (en) * | 2000-09-14 | 2005-07-12 | Pantherix, Ltd. | 3-(Heteroaryl acetamido)-2-oxo-azetidine-1-sulfonic acids derivatives as antibacterial agents |
| US20050065141A1 (en) * | 2003-07-31 | 2005-03-24 | Odink Debra A. | Carbapenems useful in treating and preventing pulmonary infections, pharmaceutical compositions thereof and modes of administration thereof |
| EP2124942B1 (en) * | 2007-03-23 | 2016-04-27 | Basilea Pharmaceutica AG | Combination medicaments for treating bacterial infections |
-
2008
- 2008-03-19 EP EP08718057.6A patent/EP2124942B1/en active Active
- 2008-03-19 BR BRPI0809147-1A patent/BRPI0809147A2/pt not_active IP Right Cessation
- 2008-03-19 CN CN2008800093460A patent/CN101641095B/zh not_active Expired - Fee Related
- 2008-03-19 WO PCT/EP2008/053336 patent/WO2008116813A2/en not_active Ceased
- 2008-03-19 MX MX2009009918A patent/MX2009009918A/es active IP Right Grant
- 2008-03-19 AU AU2008231854A patent/AU2008231854B2/en not_active Ceased
- 2008-03-19 CA CA2680018A patent/CA2680018C/en not_active Expired - Fee Related
- 2008-03-19 NZ NZ579375A patent/NZ579375A/en not_active IP Right Cessation
- 2008-03-19 RU RU2009139004/15A patent/RU2488394C2/ru not_active IP Right Cessation
- 2008-03-19 KR KR1020097019585A patent/KR101320718B1/ko not_active Expired - Fee Related
- 2008-03-19 JP JP2009554024A patent/JP2010521517A/ja active Pending
- 2008-03-19 US US12/532,243 patent/US8486929B2/en not_active Expired - Fee Related
-
2009
- 2009-09-11 ZA ZA200906349A patent/ZA200906349B/xx unknown
-
2013
- 2013-06-12 US US13/915,833 patent/US8809315B2/en not_active Expired - Fee Related
- 2013-08-19 JP JP2013169657A patent/JP5779209B2/ja not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007065288A2 (en) * | 2005-12-07 | 2007-06-14 | Basilea Pharmaceutica Ag | Useful combinations of monobactam antibiotics with beta-lactamase inhibitors |
Non-Patent Citations (8)
| Title |
|---|
| KUMIKO MAEDA ET AL.Comparison of activities of [beta]-lactam antibiotics against Streptococcus pneumoniae with recombinant penicillin-binding protein genes from a penicillin-resistant strain.《JOURNAL OF INFECTION AND CHEMOTHERAPY》.2005,第11卷(第2期),107-111. |
| KUMIKO MAEDA ET AL.Comparison of activities of [beta]-lactam antibiotics against Streptococcus pneumoniae with recombinant penicillin-binding protein genes from a penicillin-resistant strain.《JOURNAL OF INFECTION AND CHEMOTHERAPY》.2005,第11卷(第2期),107-111. * |
| MIMOZ O ET AL.Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae.《ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 》.2000,第44卷(第4期),885-890. |
| MIMOZ O ET AL.Efficacies of imipenem, meropenem, cefepime, and ceftazidime in rats with experimental pneumonia due to a carbapenem-hydrolyzing beta-lactamase-producing strain of Enterobacter cloacae.《ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 》.2000,第44卷(第4期),885-890. * |
| NARO OHASHI ET AL.Pharmacokinetics of panipenem/betamipron in patients with end-stage renal disease.《JOURNAL OF INFECTION AND CHEMOTHERAPY》.2005,第11卷(第1期),24-31. |
| NARO OHASHI ET AL.Pharmacokinetics of panipenem/betamipron in patients with end-stage renal disease.《JOURNAL OF INFECTION AND CHEMOTHERAPY》.2005,第11卷(第1期),24-31. * |
| REVILL P ET AL.Tomopenem - Carbapenem antiobiotic.《DRUGS OF THE FUTURE》.2007,第32卷(第1期),37-44. |
| REVILL P ET AL.Tomopenem- Carbapenem antiobiotic.《DRUGS OF THE FUTURE》.2007,第32卷(第1期),37-44. * |
Also Published As
| Publication number | Publication date |
|---|---|
| KR101320718B1 (ko) | 2013-10-21 |
| JP2010521517A (ja) | 2010-06-24 |
| CA2680018A1 (en) | 2008-10-02 |
| MX2009009918A (es) | 2009-10-19 |
| BRPI0809147A2 (pt) | 2014-08-26 |
| CA2680018C (en) | 2014-01-07 |
| AU2008231854A1 (en) | 2008-10-02 |
| US20130274238A1 (en) | 2013-10-17 |
| US8486929B2 (en) | 2013-07-16 |
| EP2124942B1 (en) | 2016-04-27 |
| WO2008116813A2 (en) | 2008-10-02 |
| NZ579375A (en) | 2012-02-24 |
| ZA200906349B (en) | 2010-06-30 |
| US20100144699A1 (en) | 2010-06-10 |
| AU2008231854B2 (en) | 2013-03-21 |
| JP2013253094A (ja) | 2013-12-19 |
| US8809315B2 (en) | 2014-08-19 |
| JP5779209B2 (ja) | 2015-09-16 |
| RU2009139004A (ru) | 2011-04-27 |
| EP2124942A2 (en) | 2009-12-02 |
| WO2008116813A9 (en) | 2008-11-27 |
| HK1138184A1 (en) | 2010-08-20 |
| RU2488394C2 (ru) | 2013-07-27 |
| CN101641095A (zh) | 2010-02-03 |
| KR20090122357A (ko) | 2009-11-27 |
| WO2008116813A3 (en) | 2009-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101641095B (zh) | 用于治疗细菌感染的组合药物 | |
| EP0979229B1 (en) | 2-oxo-1-azetidine sulfonic acid derivatives as potent beta-lactamase inhibitors | |
| EP1012139B1 (en) | Azetidinone derivatives as beta-lactamase inhibitors | |
| US8252782B2 (en) | Monocarbams | |
| KR101933084B1 (ko) | 화합물 및 그의 용도 | |
| CN104768951A (zh) | 1,6-二氮杂双环[3,2,1]辛-7-酮衍生物及其在治疗细菌感染中的用途 | |
| US20130244929A1 (en) | Bridged lipoglycopeptides that potentiate the activity of beta-lactam antibacterials | |
| TW474935B (en) | Cephalosporin antibiotics | |
| RU2281948C2 (ru) | Цефалоспориновые антибиотики, фармацевтическая композиция на их основе и способ лечения инфекции | |
| KR20210083285A (ko) | 모노박탐 화합물 및 그의 사용 | |
| HK1138184B (en) | Combination medicaments for treating bacterial infections | |
| IE914307A1 (en) | Heterocyclic carboxylic esters, methods for their¹preparation and their use for the preparation of¹gastro-intestinal medicines | |
| US20220204457A1 (en) | Arginine gingipain inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1138184 Country of ref document: HK |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1138184 Country of ref document: HK |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121031 Termination date: 20170319 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |